-
Apalutamide, sold
under the
brand name
Erleada among others, is a
nonsteroidal antiandrogen (NSAA)
medication used for the
treatment of
prostate cancer...
-
similar activity to that of
apalutamide and, with
apalutamide therapy,
circulates at
similar concentrations to
those of
apalutamide at
steady state.[failed...
-
impairment is unknown. Two 2020 meta-analyses
reported that
enzalutamide and
apalutamide seemed to be more
effective than
darolutamide in
improving metastasis-free...
- (also
known as
complete or
maximal androgen blockade). Enzalutamide,
apalutamide, and
abiraterone acetate are
specifically approved for use in combination...
-
diarylthiohydantoin derivative. It is
closely related to
enzalutamide and
apalutamide. Both RD-162 and
enzalutamide show 5- to 8-fold
higher affinity for the...
- ISSN 0114-9954. S2CID 195107338. "Robust PSA
Response and
Treatment Adherence of
Apalutamide in CRPC Seen with RWE".
Targeted Oncology. 10
September 2021. Retrieved...
-
antiandrogen drugs,
namely the
androgen receptor antagonists enzalutamide,
apalutamide, and darolutamide, as well as the
testosterone production inhibitor abiraterone...
- nilutamide, and
bicalutamide as well as to
newer second-generation
NSAAs like
apalutamide and proxalutamide.
Enzalutamide was
discovered by
Charles Sawyers and...
- MRK-016
Naloxone Naltrexone Nicardipine Nonsteroidal antiandrogens (e.g.,
apalutamide, bicalutamide, enzalutamide, flutamide, nilutamide)
Oenanthotoxin Pentylenetetrazol...
-
treatment of
hormone refractory prostate cancer. An
analog of enzalutamide,
apalutamide, was also FDA approved. 2022 IUPAC-Richter
Prize 2016
Glenn T. Seaborg...
